Printer Friendly

Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China.

PALO ALTO, California, March 18, 2015 /PRNewswire/ -- Vivo Capital, a healthcare investment firm with offices in Palo Alto, California, Beijing, and Shanghai, China, announced the final closing of Vivo Capital Fund VIII ("Vivo VIII") at $750 million, which brings the firm's total funds under management to more than $1.7 billion.

Vivo plans to invest the capital primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo plans to continue assisting companies in both countries in their efforts to forge cross-border partnerships, enabling companies to acquire new products and expand the market for their existing products. Vivo also intends to continue its successful strategies of building companies from scratch, identifying later stage products with a high probability of FDA approval, and investing directly in public companies.

Investors in Vivo VIII include pension funds, financial institutions, endowments, foundations, family offices, and fund of funds. In addition to limited partners that participated in Vivo's earlier funds, Vivo VIII added a number of new institutional investors from the U.S., Europe, and Asia.

About Vivo Capital Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising later development stage products in the U.S. and revenue stage companies in China. Vivo Capital ( has offices in Palo Alto, California, Beijing, China, and Shanghai, China.

To view the original version on PR Newswire, visit:</a>

COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Geographic Code:9CHIN
Date:Mar 17, 2015
Previous Article:Darktrace Raises $18m to Fund Global Expansion.
Next Article:Aluminum Heat Transfer Composites Market 2017 Forecasts for Chinese and Global Regions.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters